Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
6.70
+0.98 (17.13%)
Oct 8, 2025, 12:03 PM EDT - Market open
Evaxion Market Cap
Evaxion has a market cap or net worth of $42.32 million as of October 8, 2025. Its market cap has increased by 153.84% in one year.
Market Cap
42.32M
Enterprise Value
32.67M
1-Year Change
153.84%
Ranking
Category
Stock Price
$6.70
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $42.32M, a decrease of -77.96%. That is a compound annual growth rate of -27.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 36.13M | 628.57% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | 191.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |